UM: Synthetic Compound from Brain Hormone Shows Beneficial Effects in Preclinical Studies

UM: Synthetic Compound from Brain Hormone Shows Beneficial Effects in Preclinical Studies

Nobel Prize winner Andrew V. Schally, Ph.D., M.D.h.c., D.Sc.h.c., professor of pathology and medicine at Sylvester Comprehensive Cancer Center and the Miller School of Medicine, and his team of research scientists at the Miami Veterans Affairs Healthcare System showed that a synthetic compound based on a brain hormone spurred the growth of cancer cells in Petri dishes but had the opposite effect in live mice.

Full Story

Related posts

Stanford, UCF Study Finds People Avoid Virtual Humans in Real World

Interacting with virtual humans in an augmented reality training environment seems to carry over into…

UM New Study Identifies Molecular Aging ‘Midlife Crisis’

Just as a computer requires code to work, our bodies are regulated by molecular “programs”…

FIU Researchers agree: Brain health is about more than just age, genetics

According to the Alzheimer’s Association, more than 50 million individuals are currently living with dementia.…